Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine - PR Newswire

/PRNewswire/ -- Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced that it has been...

• Gonorrhea is on the WHO high-priority list of antimicrobial resistant bacteria
• World's first intranasal prophylactic gonorrhea vaccine candidate
• Mucosal vaccine platforms prov… [+5250 chars] Read More
  
  
  
  

  Other Stories in Health

  • New advisory offers evidence-based strategies to prevent postoperative delirium in older adults
  • Wheat flour or Ragi flour: Which one is healthier?
  • Keynote Selena Gomez spotlights prioritizing mental health during Academy Women's Luncheon
  • UVM scientists discover new mechanism for blood flow regulation in the brain
  • More cancer patients die here than in US, South Korea, Japan: Paper
  • 'Yellowstone' Season 5 Episode 13 Recap: What Happened?
  • Route to Christmas: Day 9 2024
  • Depression genes amplify women's heart disease risk
  • Measles & Rubella Weekly Monitoring Report – Week 20: May 12 to May 18, 2024